ROBERT R RECKER, M.D.
Osteopathic Medicine at 30 St, Omaha, NE
License number
Nebraska 11008
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
601 N 30Th St STE 4820, Omaha, NE 68131
Phone
(402) 280-4277
Personal information
See more information about ROBERT R RECKER at radaris.comName
Address
Phone
5224 Jones St, Omaha, NE 68106
641 S Monitor St, West Point, NE 68788
3309 S 116Th St, Omaha, NE 68144
5711 45Th St, Lincoln, NE 68516
125 Lincoln St, West Point, NE 68788
Organization information
See more information about ROBERT R RECKER at bizstanding.comCreighton University Medical Center - Robert R Recker MD
601 N 30 St #4820, Omaha, NE 68131
Categories:
Endocrinology & Metabolism Physicians & Surgeons, Physicians & Surgeons
Phone:
(402) 280-4470 (Phone)
Professional information
Robert Roy Recker, Omaha NE
Specialties:
Internal Medicine, Endocrinology, Diabetes & Metabolism
Work:
Creighton University
601 N 30Th St, Omaha, NE 68131 Alegent Health Central Billing Office
7500 Mercy Rd, Omaha, NE 68124 Physicians Of Internal Med
7710 Mercy Rd, Omaha, NE 68124
601 N 30Th St, Omaha, NE 68131 Alegent Health Central Billing Office
7500 Mercy Rd, Omaha, NE 68124 Physicians Of Internal Med
7710 Mercy Rd, Omaha, NE 68124
Education:
Creighton University (1963)
Robert L Recker, Omaha NE
Specialties:
Internist
Address:
7710 Mercy Rd, Omaha, NE 68124
2500 California Plz, Omaha, NE 68178
601 N 30Th St, Omaha, NE 68131
2500 California Plz, Omaha, NE 68178
601 N 30Th St, Omaha, NE 68131
Education:
Creighton University, School of Medicine - Doctor of Medicine
Creighton University Medical Center - Fellowship - Endocrinology, Diabetes, and Metabolism (Internal Medicine)
Creighton University Medical Center - Residency - Family Medicine
Creighton University Medical Center - Fellowship - Endocrinology, Diabetes, and Metabolism (Internal Medicine)
Creighton University Medical Center - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Dr. Robert R Recker - MD (Doctor of Medicine)
Hospitals:
Osteoporosis Research
601 N 30Th St, Omaha 68131
Alegent Creighton Health Creighton University Medical Center
601 North 30Th St, Omaha 68131
Osteoporosis Research
601 N 30Th St, Omaha 68131
Alegent Creighton Health Creighton University Medical Center
601 North 30Th St, Omaha 68131
601 N 30Th St, Omaha 68131
Alegent Creighton Health Creighton University Medical Center
601 North 30Th St, Omaha 68131
Osteoporosis Research
601 N 30Th St, Omaha 68131
Alegent Creighton Health Creighton University Medical Center
601 North 30Th St, Omaha 68131
Education:
Medical Schools
Creighton University School Of Medicine
Graduated: 1963
Creighton University School Of Medicine
Graduated: 1963
High Bone Mass Gene Of 11Q13.3
US Patent:
6770461, Aug 3, 2004
Filed:
Apr 5, 2000
Appl. No.:
09/544398
Inventors:
John P. Carulli - Southboro MA
Randall D. Little - Newtonville MA
Robert R. Recker - Omaha NE
Mark L. Johnson - Omaha NE
Randall D. Little - Newtonville MA
Robert R. Recker - Omaha NE
Mark L. Johnson - Omaha NE
Assignee:
Genome Therapeutics Corporation - Waltham MA
Creighton University School of Medicine - Omaha NE
Creighton University School of Medicine - Omaha NE
International Classification:
C12P 2100
US Classification:
435 701, 435325, 4352523, 4353201, 435 711, 435 712
Abstract:
The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof The genes identified in the present invention are implicated in bone development. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.
High Bone Mass Gene Of 1.1Q13.3
US Patent:
6780609, Aug 24, 2004
Filed:
Apr 5, 2000
Appl. No.:
09/543771
Inventors:
John P. Carulli - Southboro MA
Randall D. Little - Newtonville MA
Robert R. Recker - Omaha NE
Mark L. Johnson - Omaha NE
Randall D. Little - Newtonville MA
Robert R. Recker - Omaha NE
Mark L. Johnson - Omaha NE
Assignee:
Genome Therapeutics Corporation - Waltham MA
International Classification:
C12P 2106
US Classification:
435 691, 4353201, 435325, 435455, 4352521, 435471, 536 231, 536 235, 530350, 530380
Abstract:
The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof. The genes identified in the present invention are implicated in bone development. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.
Treatment For Osteoporosis Using Hgrf(1-40)Nh.sub.2
US Patent:
4710382, Dec 1, 1987
Filed:
Sep 27, 1985
Appl. No.:
6/780949
Inventors:
Robert R. Recker - Omaha NE
International Classification:
A61K 3702, A61K 3555
US Classification:
424108
Abstract:
A method of treating osteoporosis, especially postmenopausal osteoporosis, by administering on a periodic but regular basis to a patient growth hormone releasing factor, GRF(1-44)--NH. sub. 2, or a biologically active analog thereof, and continuing the administration until bone mass increases and the patient's calcium balance becomes positive and indicates a mineral accumulation in the skeleton.
Method And Treatment Composition For Decreasing Patient Time In Catabolic State After Traumatic Injury
US Patent:
5700775, Dec 23, 1997
Filed:
Mar 24, 1995
Appl. No.:
8/410353
Inventors:
Mark K. Gutniak - S-165 65 Hasselby, SE
Thomas R. Coolidge - Falls Village CT
Robert R. Recker - Omaha NE
Fred W. Wagner - Walton NE
Thomas R. Coolidge - Falls Village CT
Robert R. Recker - Omaha NE
Fred W. Wagner - Walton NE
International Classification:
A61K 3827, A61K 3700
US Classification:
514 12
Abstract:
A method of decreasing patient time in a catabolic state after a traumatic injury. The patient is administered systemically human growth hormone releasing factor or a biologically active analog of human growth hormone releasing factor. Administration in the case of voluntary traumatic injury such as surgery occurs just prior to commencing the surgery and thereafter continuing until recovery. In this way the time in a catabolic state is significantly decreased, and the patient moves more quickly to desired anabolic state necessary for recovery.
Treatment For Osteoporosis Using Growth Hormone Releasing Factor (Grf) In Combination With Parathyroid Hormone (Pth)
US Patent:
5164368, Nov 17, 1992
Filed:
Nov 4, 1991
Appl. No.:
7/787051
Inventors:
Robert R. Recker - Omaha NE
International Classification:
A61K 3736
US Classification:
514 12
Abstract:
A method of treating osteoporosis, especially postmenopausal osteoporosis, by administering on a periodic but regular basis to a patient growth hormone releasing factor, GRF(1-44)-NH. sub. 2, or a biologically active analog thereof, and concurrently administering parathyroid hormone, PTH(1-34)-NH. sub. 2 and continuing the administration until bone mass increases and the patient's calcium balance becomes positive and indicates a mineral accumulation in the skeleton.
High Bone Mass Gene Of 11Q13.3
US Patent:
2003021, Nov 27, 2003
Filed:
Feb 28, 2003
Appl. No.:
10/374979
Inventors:
John Carulli - Southboro MA, US
Robert Recker - Omaha NE, US
Mark Johnson - Omaha NE, US
Randall Little - Newtonville MA, US
Robert Recker - Omaha NE, US
Mark Johnson - Omaha NE, US
Randall Little - Newtonville MA, US
International Classification:
C12Q001/68, C07H021/04, C12N009/64, C12P021/02, C12N005/06, C07K016/40
US Classification:
435/006000, 435/069100, 435/226000, 435/320100, 435/325000, 536/023200, 530/388260
Abstract:
The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof. The genes identified in the present invention are implicated in bone development and in focal adhesion signaling. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.
High Bone Mass Gene Of 11Q13.3
US Patent:
7285400, Oct 23, 2007
Filed:
Dec 10, 2003
Appl. No.:
10/731739
Inventors:
John P. Carulli - Southboro MA, US
Randall D. Little - Newtonville MA, US
Robert R. Recker - Omaha NE, US
Mark L. Johnson - Omaha NE, US
Randall D. Little - Newtonville MA, US
Robert R. Recker - Omaha NE, US
Mark L. Johnson - Omaha NE, US
Assignee:
Genome Therapeutics Corporation - Waltham MA
Creighton University - Omaha NE
Creighton University - Omaha NE
International Classification:
C12P 21/00, C12N 15/63, C12N 15/11
US Classification:
435 701, 4353201, 536 231
Abstract:
The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof. The genes identified in the present invention are implicated in bone development. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.